At the last check on Friday, NextGen Healthcare Inc.’s (NASDAQ:NXGN) stock was up $0.74, moving up 4.06 percent to $18.95. The average number of shares traded per day over the past five days has been 494,026 shares. 3 times new highs have been achieved over the past 5 days, with a $0.84 gain in that time frame. In the last twenty days, the average volume was 519,346, while in the previous 50 days, it was 403,923.
Since last month, NXGN stock rose 14.50%. Shares of the company fell to $16.03 on 08/21/23, the lowest level in the past month. A 52-week high of $21.99 was reached on 02/15/23 after having rallying from a 52-week low of $15.23. Since the beginning of this year, NXGN’s stock price has risen by 0.91% or $0.01, and marked a new high 5 times. However, the stock has declined by -13.82% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
NXGN stock investors should be aware that NextGen Healthcare Inc. (NXGN) stock had its last reported insider trading activity 274 days ago on Dec 01. Metcalfe David A, the Chief Technology Officer of the company, disposed of 32,372 shares for $20.58 on Dec 01. It resulted in a $666,135 divestment by the insider. Waters Mitchell sold 9,783 shares at an average price of $20.50 on Nov 08. The insider now owns 70,469 shares following the transaction. On Nov 01, Chief Technology Officer Metcalfe David A sold 32,372 shares at $20.00 apiece. The transaction was valued at $647,485.
Valuation Metrics
Right now, NextGen Healthcare Inc. (NXGN) has a P/E ratio of about 758.00. The stock’s beta is 0.99. Besides these, the trailing price-to-sales (P/S) ratio of 1.86, the price-to-book (PB) ratio of 3.07, and the price-to-cash flow ratio of 341.51 may also be considered.
Financial Health
In the three months ended June 29, NextGen Healthcare Inc.’s quick ratio stood at 2.20, while its current ratio was 2.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.65, and the total debt-to-equity ratio was 0.65. On the profitability front, the trailing twelve-month gross margin is 46.90% percent. In the year ended June 29, EBITDA margin amounted to 6.63%, whereas operating margins totaled 0.60%. Based on annual data, NXGN earned $311.16 million in gross profit and brought in $653.17 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -1.60%. Return on equity (ROE) for the past 12 months was 0.60%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. NXGN’s revenue rose 13.98% to $178.55 million during the quarter, while net income inched up to $178.21 million. While analysts expected NextGen Healthcare Inc. to report $0.22 quarterly earnings, the actual figure was $0.24 per share, beating the consensus estimate by 9.10%. During the quarter, the company generated $17.83 million in EBITDA. The liabilities of NextGen Healthcare Inc. were 457.95 million at the end of its most recent quarter ended June 29, and its total debt was $274.01 million. The value of shareholders’ equity is $67.02 million.
Technical Picture
This quick technical analysis looks at NextGen Healthcare Inc.’s (NXGN) price momentum. With a historical volatility rate of 28.83%, the RSI 9-day stood at 76.54% on 31 August.
With respect to its five-day moving average, the current NextGen Healthcare Inc. price is up by +4.68% percent or $0.84. At present, NXGN shares trade +12.92% above its 20-day simple moving average and +9.75% percent above its 100-day simple moving average. However, the stock is currently trading approximately +17.73% above its SMA50 and -6.28% below its SMA200.
Stochastic coefficient K was 94.17% and Stochastic coefficient D was 92.20%, while ATR was 0.50. Given the Stochastic reading of 97.18% for the 14-day period, the RSI (14) reading has been calculated as 72.69%. As of today, the MACD Oscillator reading stands at 0.55, while the 14-day reading stands at 1.12.
Analyst Ratings
Cantor Fitzgerald launched its rating on NextGen Healthcare Inc. (NASDAQ: NXGN) to an Overweight in a note to investors on August 28, 2023. NextGen Healthcare Inc. (NXGN) has been rated Overweight by analysts. According to 0 brokerage firms, NXGN is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate NextGen Healthcare Inc. stock as buy, with 4 recommending it as overweight.
With a median target price of $21.00, the current consensus forecast for the stock is $17.00 – $24.00. Based on these forecasts, analysts predict NextGen Healthcare Inc. (NXGN) will achieve an average price target of $20.24.
